Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.25M Sell
91,996
-44,303
-33% -$1.79M ﹤0.01% 1104
2026
Q1
$4.52M Sell
136,299
-12,947
-9% -$421K 0.01% 1097
2025
Q4
$4.88M Sell
149,246
-40,723
-21% -$1M 0.01% 1012
2025
Q3
$3.39M Sell
189,969
-2,119
-1% -$30.7K ﹤0.01% 1123
2025
Q2
$2.08M Buy
192,088
+47,554
+33% +$623K ﹤0.01% 1312
2025
Q1
$2.67M Buy
+144,534
New +$2.61M ﹤0.01% 1084

Other funds holding AXGN

Mariner's AXGN Position: Q2 2026 in Review

Mariner reduced its Axogen (AXGN) stake by 33% in Q2 2026, selling an estimated $1.79M and leaving 91,996 shares worth $4.25M. The position accounts for ﹤0.01% of the portfolio, ranked #1104.

Mariner first reported a position in AXGN in Q1 2025 and has held it in 6 quarters since. The position peaked at $4.88M in Q4 2025. 254 funds tracked by Wall St. Rank hold AXGN as of Q2 2026.

  • Mariner held 91,996 shares of Axogen worth $4.25M as of Q2 2026.
  • Mariner sold 44,303 Axogen shares in Q2 2026, an estimated $1.79M.
  • Axogen made up ﹤0.01% of Mariner's portfolio in Q2 2026, its #1104 holding.
  • Mariner first reported a position in Axogen in Q1 2025 and has held it in 6 quarters since.
  • Mariner's Axogen position peaked at $4.88M in Q4 2025.
  • 254 funds tracked by Wall St. Rank held Axogen as of Q2 2026.

Based on Mariner's 13F filing for Q2 2026, filed 13 Aug 2026.